AI assistant
IRLAB Therapeutics Major Shareholding Notification 2020
3062_iss_2020-12-30_3981f8f4-c96d-4d58-9f19-d5f9d56f06cf.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer IRLAB Therapeutics AB
Holder
Fjärde AP-fonden
Instrument
| Instrument | Aktie | |||
|---|---|---|---|---|
| Before the transaction | ||||
| Shares | 2,419,366 | |||
| Voting rights | 2,419,366 | |||
| Transaction | ||||
| Date | 30/12/2020 | |||
| Limit for number of shares 5 % | ||||
| Limit for number of votes | 5 % |
After the transaction
Quantity
| Shares | 3,044,366 |
|---|---|
| Directly held voting rights 3,044,366 | |
| Indirectly held voting rights 0 |
Percentage
Directly held shares 5.88 % Directly held voting rights 5.88 % Indirectly held voting rights 0 %
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.88 % | 3,044,366 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, |
||
| first paragraph, line 3 | ||
| - Physically settled - Cash settled |
||
| Total | 5.88 % | 3,044,366 |
| Group total holdings |
||
| Voting rights 3,044,366 |
||
| Percentage of voting rights 5.88 | ||
| Published | ||
| 30/12/2020 20:39 | ||
| Contact | ||
| Name Jannis Kitsakis |
||
| Phone 070-6038023 Email [email protected] |
||
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25